Mochida Pharmaceutical Co Ltd
MFY
Company Profile
Business description
Mochida Pharmaceutical Co Ltd is a drug manufacturing company engaged in manufacturing, procurement, and sale of pharmaceutical and healthcare-related product. The company operates in the field of medical care through its pharmaceuticals, healthcare products, and medical equipment businesses. The company's pharmaceuticals business aims to develop and market a broad spectrum of creative new drugs. The healthcare segment entrusts the manufacturing of healthcare products.
Contact
1-7 Yotsuya
Shinjuku-ku
Tokyo160-8515
JPNT: +81 333587211
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2027
Employees
1,966
Stocks News & Analysis
stocks
Ahead of an IPO, the maths behind Databrick’s $190 billion valuation doesn’t add up
The data and AI company is one of the world’s strongest private companies, but a PitchBook report says it’s unattractive at the current price.
stocks
Takeover proposal agreed for ASX share, other offers permitted
Morningstar analysts’ take on the takeover for this undervalued industrial player.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,919.10 | 3.60 | -0.04% |
| CAC 40 | 8,138.94 | 73.92 | 0.92% |
| DAX 40 | 25,575.01 | 270.95 | 1.07% |
| Dow JONES (US) | 52,003.74 | 321.10 | 0.62% |
| FTSE 100 | 10,739.01 | 79.88 | 0.75% |
| HKSE | 25,042.71 | 291.93 | 1.18% |
| NASDAQ | 27,052.22 | 529.68 | 2.00% |
| Nikkei 225 | 65,018.95 | 882.70 | 1.38% |
| NZX 50 Index | 13,821.20 | 82.06 | 0.60% |
| S&P 500 | 7,754.02 | 103.52 | 1.35% |
| S&P/ASX 200 | 8,731.90 | 0.70 | 0.01% |
| SSE Composite Index | 3,949.91 | 38.04 | 0.97% |